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ABSTRACT
Aims To assess tobacco dependence treatment guidelines content in accordance with Article 14 of theWorld Health Or-
ganization (WHO) Framework Convention on Tobacco Control (FCTC) and its guidelines, and association between content
and country income level. Design Cross-sectional study. Setting On-line survey from March to July 2016.
Participants Contacts in 77 countries, including 68 FCTC Parties, six Signatories and three non-Parties which had in-
dicated having guidelines in previous surveys, or had not been surveyed before.Measurements A nine-item question-
naire on guidelines content, key recommendations, writing and dissemination. Findings We received responses from
contacts in 63 countries (82%); 61 had guidelines. The majority are for doctors (93%), primary care (92%) and nurses
(75%). All recommend brief advice, 82% recording tobacco use in medical notes, 98% nicotine replacement therapy
(NRT), 61% quitlines, 31% text messaging and 87% intensive specialist support, and 54% stress the importance of
health-care workers not using tobacco. Only 57% have a dissemination strategy, and 62% have not been updated for
5 or more years. Compared with high-income countries, quitlines are less likely to be recommended in upper middle-
income countries guidelines [odds ratio (OR) = 0.15, 95% conﬁdence interval (CI) = 0.04–0.61] and intensive specialist
support in lower middle-income countries guidelines (OR = 0.01, 95% CI = 0.00–0.20). Guidelines updating is associated
positively with country income level (P=0.027). Conclusions Althoughmost tobacco dependence treatment guidelines
in the 61 countries assessed in 2016 follow the World Health Organization’s Framework Convention on Tobacco Control
Article 14 recommendations and do not differ signiﬁcantly by income level, improvements are needed in keeping guide-
lines up-to-date, applying good writing practices and developing a dissemination strategy.
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INTRODUCTION
Article 14 of the World Health Organization (WHO)
Framework Convention on Tobacco Control (FCTC)
requires Parties to develop and disseminate compre-
hensive guidelines based on scientiﬁc evidence, and
to take effective measures to promote cessation of
tobacco use and adequate treatment for tobacco de-
pendence [1].
Guidelines for the implementation of Article 14,
adopted at the fourth Conference of the Parties to the FCTC
in 2010, provide more detailed recommendations and out-
line the key characteristics of national tobacco treatment
guidelines [2] which should:
• be evidence-based;
• be comprehensive, and include a broad range of inter-
ventions; for example, brief advice, quitlines, behavioural
support and cessation medications;
• cover all settings and providers, both within and outside
the health-care systems;
• include a dissemination and implementation plan;
• stress the importance of all service providers setting an
example by not using tobacco, and that they be offered
help to stop;
• be developed in active collaboration with key stake-
holders, including health professional organizations;
• be endorsed widely at national level by health profes-
sional organizations and/or associations;
© 2018 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction. Addiction
RESEARCH REPORT doi:10.1111/add.14204
This is an open access article under the terms of the Creative CommonsAttribution-NonCommercial License, which permits use, distribution and reproduction
in any medium, provided the original work is properly cited and is not used for commercial purposes.
• be protected from all actual and potential conﬂicts of in-
terest; and
• be reviewed periodically and updated in light of new sci-
entiﬁc evidence.
Previous surveys identiﬁed 31 guidelines in 2007 and
53 in 2012 [3,4]. In our most recent (2015) global survey
of tobacco treatment provision, in 142 countries, we iden-
tiﬁed 57 guidelines [5]. The treatment survey also found
that more than half of high-income countries had guide-
lines (63%), while fewer than half of middle-income and
only one low-income country (LIC) did [5], showing a
strong association between having guidelines and country
income-level. It is not known if this income gradient is
reﬂected in the content of the guidelines and theway coun-
tries with different income levels follow the recommenda-
tions of Article 14 and its guidelines.
In this paper we report the results of a survey of the con-
tent of the guidelines, with the aims of (1) assessing how
well they follow the recommendations of the 2010 FCTC
Article 14 guidelines; and (2) assessing the association be-
tween guideline content and country income-level.
METHODS
Survey participants
We approached all Parties (n = 68) and Signatories
(n = 2) that conﬁrmed having treatment guidelines
in any of the previous surveys. We also tried to
reach another 14 countries that were not Parties or
Signatories at the time of the survey and were not
surveyed previously, and found contacts in seven of
them. We did not approach Parties that said they
did not have guidelines in 2015 (n = 85) and non-
respondents (n = 30) in the 2015 survey. The reason
for excluding the non-respondents was that they did
not reply to our multiple attempts to contact them
previously.
Our ﬁnal survey sample consisted of 64 FCTC Parties
plus the United Kingdom (one Party but comprising four
countries; England, Scotland, Northern Ireland andWales,
each with their own health-care system and therefore sur-
veyed individually), six Signatories and three non-Parties
at the time of the survey, a total of 77 countries
(Supporting information, Table S1). We did not ﬁnd con-
tacts for one Signatory and six non-Parties.
For the countries surveyed before we invited the same
contacts from our previous treatment survey [5] to take
part by e-mail. For countries not surveyed before, we iden-
tiﬁed contacts with the help of the WHO regional ofﬁces,
the Framework Convention Alliance (FCA), Action on
Smoking and Health (USA) and other professional
networks and contacts. The contacts were a mixture of
tobacco control government ofﬁcials, members of non-
governmental health organizations and tobacco cessation
treatment specialists.
The questionnaire, adapted from our previous survey,
contained nine items based on the Article 14 guidelines
key recommendations. We sent a draft to around 10
international tobacco treatment experts known to the
authors, most of whom helped to design the previous
survey questionnaire. They included researchers and
government ofﬁcials. We amended the questionnaire in
line with their feedback. The ﬁnal version included
questions on the guidelines evidence base, evidence-
based interventions, who the guidelines were for, cessa-
tion medications, the writing and review process, funding
and dissemination.
We e-mailed our contacts in March 2016 and asked
them to complete the questionnaire in an attached Word
ﬁle (available in English, French, Spanish and Russian) or
on-line (English only). We sent reminder e-mails to non-
respondents every 2 weeks between March and June
2016. Where responses were incomplete or unclear, we
asked for additional information or clariﬁcation. The sur-
vey was closed at the end of July 2016.
Survey responses were analysed by countries’ World
Bank (WB) income classiﬁcation on 1 July 2015 [6]. We
used the Cochrane Armitage statistic to test association be-
tween guideline content and income level and explored sig-
niﬁcant ﬁndings using logistic regression.
The statistical analyses were conducted in Stata version
14. In order to assess how recently guidelines had been up-
dated, we checked the year of publication of previous ver-
sions for each country, using data from our 2007, 2012
and 2015 surveys [3–5].
We use the following abbreviations for income level:
high-income countries (HIC), upper middle-income coun-
tries (UMIC), lower middle-income countries (LMIC) and
low-income countries (LIC).
RESULTS
Survey response rate
We received responses from contacts in 63 of the 77 coun-
tries (82%). Two reported not havingguidelines, and the re-
maining 61 included 57 Parties and four Signatories that
reportedhavingguidelinesandcompletedthequestionnaire
(see Supporting information, Table S1). A list of countries
with guidelines is also available on-line (see Supporting in-
formation, Table S2).
Guidelines by region and income level
Sixty-four per cent of the 61 countries with guidelines were
HIC, 21% UMIC and 15% LMIC. No LIC reported having
guidelines. By WHO region, 56% were in Europe, 18% in
the Americas, 13% in the Western Paciﬁc, 10% in the
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Eastern Mediterranean, 3% in South East Asia and none in
Africa.
Guideline content
Key recommendations
All guidelines recommend brief advice, 82% recom-
mend recording tobacco use in medical notes, 98%
recommend smoking cessation medications, 61% rec-
ommend quitlines, 31% recommend text messaging,
87% recommend intensive specialist support and 54%
stress the importance of health-care workers (HCWs)
setting an example by not using tobacco (Table 1).
Quitlines were less likely to be recommended in UMIC
compared with HIC [odds ratio (OR) = 0.15, 95% con-
ﬁdence interval (CI) = 0.04–0.61], while intensive spe-
cialist support was less likely to be recommended in
LMIC compared with HIC (OR = 0.01, 95% CI = 0.00–
0.20) (Supporting information, Table S3).
Smoking cessation medications
Almost all guidelines, 98%, recommend nicotine replace-
ment therapy (NRT), 84% recommend bupropion, 82%
recommend varenicline and 11% recommend cytisine
(Table 1). Bupropion was less likely to be recommended
in LMIC compared with HIC (OR = 0.10, 95% CI = 0.02–
0.61), while cytisine was more likely to be recommended
(OR= 14.8, 95% CI = 2.13–102.71) (Supporting informa-
tion, Table S3).
Other content
Around two-thirds (66%) reference or refer to the
Cochrane Library, 72% reference or refer to guidelines of
other countries and 59% are based on another country’s
guidelines or other guidelines; just over half (54%) of
guidelines include evidence of cost-effectiveness
(Table 1). Compared to HIC, LMIC guidelines were less
likely to contain references to the Cochrane Library
(OR = 0.04, 95% CI = 0.00–0.39) (Supporting information,
Table S3).
Professions, settings and client groups the guidelines were for
Almost all guidelines, 92%, are for primary care, and just
over three-quarters for health service managers and
smoking cessation specialists; 93% are for doctors, 75%
for nurses, 53% for dentists and 48% for pharmacists.
Two-thirds (67%) include hospitals, 53% addiction ser-
vices and 48%mental health services; 76% cover pregnant
tobacco users and 23% smokeless tobacco users. UMIC and
LMIC country guidelines are likely to cover fewer health-
care professionals and settings compared with HIC. The
trend is signiﬁcant for doctors (P = 0.039), nurses
(P = 0.001), pharmacists (P < 0.001), dentists
(P = 0.012), smoking cessation specialists (P = 0.046)
and primary care (P = 0.030). A similar trend was
Table 1 Guidelines content by World Bank income level, % Yes (n).
Question All (61) HIC (39) UMIC (13) LMIC (9) P-value for trend
Do the guidelines recommend brief advice? 100 (61) 100 (39) 100 (13) 100 (9) –
Do the guidelines recommend recording tobacco use in
patients’ medical notes?
82 (50) 85 (33) 69 (9) 89 (8) 0.855
Do the guidelines recommend quitlines? 61 (37) 74 (29) 31 (4) 44 (4) 0.017a
Do the guidelines recommend text messaging? 31 (19) 33 (13) 31 (4) 22 (2) 0.539
Do the guidelines recommend intensive specialist support? 87 (53) 97 (38) 92 (12) 33 (3) < 0.001b
Do the guidelines stress the importance of health-care workers
setting an example by not using tobacco?
54 (33) 51 (20) 69 (9) 31 (4) 0.937
Do the guidelines include evidence on cost-effectiveness? 54 (33) 59 (23) 62 (8) 22 (2) 0.100
Do the guidelines reference or refer to the Cochrane Library? 66 (40) 74 (29) 77 (10) 11 (1) 0.003c
Do the guidelines reference or refer to the guidelines of other
countries?
72 (44) 67 (26) 92 (12) 67 (6) 0.529
Are the guidelines based on another country’s guidelines or
other guidelines?
59 (36) 49 (19) 77 (10) 78 (7) 0.094
Do the guidelines recommend NRT? 98 (60) 100 (39) 92 (12) 100 (9) 0.505
Do the guidelines recommend bupropion? 84 (51) 92 (36) 77 (10) 56 (5) 0.008d
Do the guidelines recommend varenicline? 82 (50) 87 (34) 75 (9) 78 (7) 0.354
Do the guidelines recommend cytisine? 11 (7) 5 (2) 8 (1) 44 (4) 0.003e
HIC = high-income countries; UMIC = upper middle-income countries; LMIC = lower middle-income countries; NRT = nicotine replacement therapy. Odds
ratios (OR), 95% conﬁdence interval (CI) where P-value for trend is signiﬁcant. aHIC = 1: UMIC, OR = 0.15, 95% CI = 0.04–0.61; LMIC: OR = 0.28, 95%
CI = 0.06–1.23; bHIC = 1; UMIC, OR = 0.32, 95% CI = 0.01–5.44; LMIC: OR = 0.01, 95% CI = 0.00–0.20; cHIC =1: UMIC, OR = 1.15, 95% CI = 0.26–
5.03; LMIC: OR = 0.04, 95% CI = 0.00–0.39; dHIC = 1: UMIC, OR = 0.42, 95% CI = 0.06–2.84; LMIC: OR = 0.10, 95% CI = 0.02–0.61; eHIC = 1: UMIC,
OR = 0.16, 95% CI = 0.30–0.80; LMIC: OR = 14.8, 95% CI = 2.13–102.71.
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observed with mental health services (P = 0.048) and
pregnant tobacco users (P = 0.044) in UMIC and LMIC
(Table 2). Compared with HIC, LMIC guidelines were less
likely to cover nurses (OR = 0.07, 95% CI = 0.01–0.40)
and dentists (OR = 0.16, 95% CI = 0.03–0.87)
(Supporting information, Table S4).
Guidelines writing, dissemination and funding
Sixty-one per cent of guidelines describe thewriting and re-
view process clearly. National professional associations par-
ticipated in the writing and review process of 77% of
guidelines, and 66% are endorsed formally by them; 67%
are formally endorsed or supported by the national govern-
ment, and 61% were peer-reviewed. Sixty-nine per cent
are published on-line, 74% as a book or report and 21%
in a peer-reviewed journal. Forty-one per cent of guidelines
include conﬂict-of-interest statements for all authors; 69%
received ﬁnancial support from government or other public
health organization, 13% received ﬁnancial support from
the pharmaceutical industry and 8% include the names
and/or logos of pharmaceutical companies (Table 3).
Fifty-seven per cent had a dissemination strategy.
Compared with HIC, UMIC guidelines were less likely to
contain conﬂict-of-interest statements (OR = 0.16, 95%
CI = 0.30–0.80) (Supporting information, Table S3).
Year of publishing and updating guidelines
We were uncertain of the year of publication of one
country’s guidelines and excluded it from the analyses,
leaving 60 countries that conﬁrmed year of publishing
and/or updating. Of these 60, ﬁve (8%) published guide-
lines for the ﬁrst time since 2012, 18 (30%) had updated
their guidelines since 2012 and 37 (62%) had not up-
dated their guidelines since 2012, including all LMIC,
75% of UMIC and 58% of HIC. Guidelines updating
was associated positively with income level (P-value for
trend = 0.027).
Compared with guidelines not updated since 2012,
more recently updated or written guidelines recommended
quitlines (83% compared with 49%, P = 0.007) and inten-
sive cessation support (100% compared with 78%,
P = 0.024) (Table 4).
DISCUSSION
We identiﬁed 61 countries with treatment guidelines, ﬁve
of which had produced them since 2012. The guidelines
are distributed disproportionately by income level and re-
gion, as in our 2012 survey [4]. More than two-thirds
are high-income, one-third middle-income; and no low-
income countries had guidelines. More than half are in
Europe and fewer than 20% in each of the other WHO
regions, except Africa, which still has no country with
guidelines. As in the 2012 survey [4] most guidelines
are broadly evidence-based. All recommend brief advice
and almost all recommend smoking cessation medica-
tions. More than 80% recommend recording tobacco
use in medical notes and intensive specialist support,
and more than half stress the importance of health-care
Table 2 Professions, settings and client groups covered in the guidelines, % yes (n).
Question All (61) HIC (39) UMIC (13) LMIC (9) P-value for trend
Which professions, settings, and client groups do they include:
Doctors? 93 (57) 97 (38) 92 (12) 78 (7) 0.039
Nurses? 75 (46) 87 (34) 69 (9) 33 (3) 0.001a
Pharmacists? 48 (29) 62 (24) 31 (4) 11 (1) < 0.001b
Dentists? 53 (32) 64 (25) 39 (5) 22 (2) 0.012c
Smoking cessation specialists? 77 (47) 85 (33) 69 (9) 56 (5) 0.046d
Health-care service managers? 76 (35) 59 (23) 62 (8) 31 (4) 0.534
Primary care? 92 (56) 97 (38) 85 (11) 78 (7) 0.030e
Hospitals? 67 (41) 72 (28) 69 (9) 31 (4) 0.160
Mental health services? 48 (29) 56 (22) 39 (5) 22 (2) 0.048f
Addiction services? 53 (32) 59 (23) 39 (5) 31 (4) 0.261
Prisons? 15 (9) 21 (8) 8 (1) 0 (0) 0.083
Smokeless tobacco users? 23 (14) 28 (11) 15 (2) 11 (1) 0.203
Pregnant tobacco users? 76 (35) 67 (26) 46 (6) 33 (3) 0.044g
Other? 25 (15) 21 (8) 39 (5) 22 (2) 0.582
HIC = high-income countries; UMIC = upper middle-income countries; LMIC = lower middle-income countries. Odds ratios (OR), 95% conﬁdence inter-
val (CI) where P-value for trend is signiﬁcant. aHIC = 1: UMIC, OR = 0.33, 95% CI = 0.07–1.49; LMIC, OR = 0.07, 95% CI = 0.01–0.40; bHIC = 1:
UMIC, OR = 0.27, 95% CI = 0.07–1.06; logistic regression not possible for LMIC, as only one value; cHIC = 1: UMIC, OR = 0.35, 95% CI = 0.10–1.28;
LMIC, OR = 0.16, 95% CI = 0.03–0.87; dHIC =1, UMIC OR 0.41 (95% CI 0.09 – 1.77); LMIC OR 0.23 (95% CI 0.05 – 1.10); eHIC = 1: UMIC,
OR = 0.14, 95% CI = 0.01–1.76; LMIC, OR = 0.09, 95% CI = 0.01–1.16; fHIC =1: UMIC, OR = 0.48, 95% CI = 0.13–1.74; LMIC, OR = 0.22,
95% CI = 0.04–1.20; gHIC =1: UMIC, OR = 0.43, 95% CI = 0.12–1.54; LMIC, OR = 0.25, 95% CI = 0.05–1.16.
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workers not using tobacco. Fewer than two-thirds recom-
mend quitlines and fewer than one-third recommend
text messaging. There were important differences in
guidelines content by income; for example, middle-
income country guidelines covered fewer health-care pro-
fessionals and settings compared with HIC.
Strengths and limitations
To our knowledge, this is themost comprehensive survey of
national tobacco treatment guidelines to date. We identi-
ﬁed contacts in all countries that previously said they had
guidelines, as well as in additional countries for which such
information was not available at the time of the survey.
For this survey we tried to identify all countries with
guidelines. We did not approach countries that did not re-
spond or responded that they did not have guidelines in the
2015 survey. As the majority were low- and lower-middle
income, it was highly unlikely for these countries to have
developed treatment guidelines during the short period of
time (just 1 year) between the two surveys. Of the 30 coun-
tries not included in the survey, 17 were low- or lower
middle-income, 10 upper middle-income and three high-
income. Although it can be speculated that it is possible
Table 3 Guidelines writing and review process by World Bank income level, % Yes (n).
Question
All
(61)
HIC
(39)
UMIC
(13)
LMIC
(9)
P-value for
trend
Do the guidelines clearly describe the writing and review process? 61 (37) 66 (25) 62 (8) 44 (4) 0.268
Did national professional associations participate in drafting or
reviewing them?
77 (47) 80 (31) 77 (10) 67 (6) 0.441
Are they formally endorsed by national professional associations? 66 (40) 67 (26) 62 (8) 67 (6) 0.906
Are they formally endorsed or supported by your national government? 67 (41) 67 (26) 62 (8) 78 (7) 0.670
Were they peer-reviewed? 61 (37) 67 (26) 62 (8) 38 (3) 0.122
Do they include conﬂict-of-interest statements for all authors? 41 (25) 54 (21) 15 (2) 22 (2) 0.019a
Is there a strategy to disseminate the guidelines? 57 (35) 66 (25) 54 (7) 33 (3) 0.075
Where are the guidelines published?
In a peer-reviewed scientiﬁc journal 21 (13) 26 (10) 23 (3) 0 (0)
As a report/book 74 (45) 74 (29) 85 (11) 56 (5)
On-line 69 (42) 74 (29) 69 (9) 50 (4)
Other 3 (2) 0 (0) 0 (0) 22 (2)
Do they state clearly who funded the guidelines? 66 (40) 72 (28) 54 (7) 56 (5) 0.179
Did they receive ﬁnancial support from government or other public
health organizations?
69 (42) 72 (28) 62 (8) 67 (6) 0.429
Did they receive ﬁnancial support from the pharmaceutical industry? 13 (8) 14 (6) 0 (0) 22 (2) 0.863
Do the names and/or logos of any pharmaceutical companies appear
in the guidelines?
8 (5) 11 (4) 0 (0) 11 (1) 0.716
HIC= high-income countries; UMIC= uppermiddle-income countries; LMIC= lowermiddle-income countries. Odds ratios (OR), 95% conﬁdence interval (CI)
where P-value for trend is signiﬁcant. aHIC = 1; UMIC, OR= 0.16, 95% CI= 0.30 – 0.80.
Table 4 Comparison between guidelines published or updated before and after 2012.
Guideline recommendations, % Yes (n)
Guidelines updated before
2012 (n = 37)
Guidelines updated or published
after 2012 (n = 23)
P-value for
difference
Recording tobacco use in medical notes 76 (28) 91 (21) P = 0.181
Brief advice 100 (37) 100 (23) –
NRT 100 (37) 100 (23) –
Bupropion 81 (30) 91 (21) P = 0.133
Varenicline 76 (28) 91 (21) P = 0.059
Cytisine 14 (5) 10 (2) P = 0.654
Specialized support 78 (29) 100 (23) P = 0.024
Quitlines 49 (18) 83 (19) P = 0.007
Text messaging 24 (9) 44 (10) P = 0.192
Stress the importance of health-care workers
setting an example by not using tobacco
53 (20) 57 (13) P = 0.982
NRT = nicotine replacement therapy.
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for some of these countries to have had, or to have conse-
quently developed, treatment guidelines, of the 12 that
responded in the 2012 survey only two reported guide-
lines. The remaining 18 countries did not respond to any
of our previous surveys (2012 and 2015); hence, we have
been unable to verify their guidelines status.
Except for the 11 countries that reported guidelines
in the 2015 survey but did not respond in this survey,
the countries in the sample represent 84% of all FCTC
Parties known to have guidelines and 83% of Signatories.
As we identiﬁed contacts in only three of the nine non-
Parties, and only one replied, we could not conﬁrm
guidelines status for most of the non-Parties. Given that
the majority of non-Parties are low-income countries,
we believe it unlikely that many of these countries have
guidelines yet.
The main limitation of this survey is that it was not
practically possible to verify fully the accuracy of re-
sponses against the actual guidelines content. Wherever
possible we asked respondents to send us a copy of, or
a web link to, their guidelines with their completed sur-
vey to verify that the guidelines documents existed and
were available to access on-line or in another format.
We have not inspected the content of the documents
sent to us in detail, as that would go beyond the aims
and scope of the study, and would also require ﬂuency
in a large number of languages, making it practically
impossible.
Another limitation of the survey is that assessing guide-
lines implementation was beyond its scope.
As the majority of respondent countries were high-
income (twice as many as low- and middle-income), this
created imbalances in terms of sample sizes and limited
the use of statistical regression analysis in making compar-
ison across income categories.
Guidelines content and key recommendations
As in our 2012 survey, most guidelines are evidence-based
and recommend brief advice, smoking cessation medica-
tions and intensive specialist support. Only half recom-
mend HCWs setting an example by not using tobacco,
consistent with the ﬁndings from the treatment survey
[5]. Given the high reported rates of tobacco use by HCWs
and students in some countries [7–10], this remains a seri-
ously neglected area.
Most guideline recommendations did not differ signif-
icantly by countries’ income-level, the exceptions being
quitlines, intensive specialist support and some medica-
tions with data suggesting cost to be a factor. Given that
these interventions require considerable resources this is
perhaps not surprising, and is consistent with the ﬁnding
from our survey of treatment provision, that UMIC and
LMIC have less cessation support provision [5]. It is also
worth noting that our treatment survey found that, over-
all, only 23% of countries had national quitlines, very
few in LMIC and none in LIC [5]. The most important
implication of this may be that as new mobile technology
develops, text messaging systems and mobile phone ap-
plications may prove a far more cost-effective way of of-
fering support to whole populations. However, only
31% of guidelines are currently recommending text mes-
saging for cessation.
Many guidelines still fall short of good practice in the
writing process, as recommended in the FCTC Article 14
guidelines. Only around two-thirds describe the writing
and review process clearly, are peer-reviewed and state
clearly who funded the guidelines, and fewer than half in-
clude conﬂict-of-interest statements for all authors. The ﬁg-
ures are a little better for endorsement by national
professional associations (66%) and the government
(67%). Lack of government backing and wide endorsement
at national level could seriously undermine the authority of
guidelines and undermine their implementation. Also, lack
of transparency over authors’ conﬂicts of interest is likely to
undermine the authority and credibility of guidelines, as is
pharmaceutical industry funding.
Given understandable suspicion about the potential in-
ﬂuence of pharmaceutical industry funding on guideline
content, we are surprised to see that some guidelines are
still pharma-funded, and believe countries need to follow
the FCTCArticle 14Guidelinesmore rigorously if theywish
their guidelines to have credibility. The current New
Zealand guidelines are a model of good practice in this re-
spect [11]. The FCTC Article 14 guidelines state that devel-
opment of strategies to implement Article 14 should be
protected from all actual and potential conﬂicts of interest.
Guidelines updating and strategies for implementation
Nearly two-thirds of guidelines were published or up-
dated more than 5 years ago and 13% have not been up-
dated since they were ﬁrst published, some more than
10 years ago. A third recommend text messaging, the
evidence base for which has grown since the last survey
[12,13], which illustrates the need for countries to up-
date their guidelines periodically in order to reﬂect the
evidence base, something clearly recommended in the
FCTC Article 14 guidelines.
However, regular updating has cost implications and
may be an issue for UMIC and LMIC, and it is interesting
that referencing the Cochrane Library was less common
in these countries. Although the residents of more than
100 low- and middle-income countries currently have free
access to the Cochrane Library [14] through a number of
initiatives, this may not apply to all countries. However,
this ﬁnding may reﬂect broader factors. For example,
lower-income countries are likely to have ofﬁcials in charge
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who have to deal with all tobacco control, not just treat-
ment, and possibly other topics as well, and simply have
limited knowledge/expertise, limited time and possibly even
poor internet access.
One way of dealing with this may be basing guidelines
on those of other countries, which more than half say they
do. However, national guidelines must be, by deﬁnition, for
the country’s own health-care system, andmust reﬂect the
resources available. Tools are now available to help coun-
tries write or update their guidelines, including a library
of national guidelines [15] and a review of the evidence
base written especially for guideline development, which
includes an affordability calculator for use within a coun-
try, using national data [13]. This review was used by
New Zealand to update their guidelines [11], and could
serve as a simple and affordable approach other countries
could adopt.
The FCTCArticle 14 guidelines emphasize that national
cessation guidelines should have a dissemination and im-
plementation plan. In this survey, only 57% of countries
say they have a strategy to disseminate their guidelines.
Dissemination strategies and action plans are crucial
for the implementation of guideline recommendations. It
is important that countries which have produced cessation
guidelines without a dissemination strategy and imple-
mentation plan ensure that they are disseminated widely
at national level, and that practical steps are taken to im-
plement them in real life.
Overall our ﬁndings suggest that—as for treatment pro-
vision—producing tobacco cessation guidelines is a low
priority. Twelve years after the FCTC came into force and
7 years after the Article 14 guidelines were adopted, most
countries still do not have ofﬁcial national cessation guide-
lines. According to our global treatment survey, fewer than
a third of countries have an ofﬁcial national tobacco cessa-
tion strategy [5]. Although this survey was of cessation
guideline content, we believe there is now a need for a sur-
vey of national cessation strategies to assess their coverage
and content.
We suggest that countries need to look afresh at the
recommendations of the FCTC Article 14 guidelines and
implement them, using available tools to develop national
strategies and guidelines quickly and affordably [2].
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